![Kjell Rudolf Peter Edman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kjell Rudolf Peter Edman
Direttore/Membro del Consiglio presso Edman Life Science AB
Patrimonio netto: 3 748 $ in data 31/05/2024
Profilo
Kjell Rudolf Peter Edman is currently the Director at Edman Life Science AB.
He has previously worked as the Director-Global Development at AstraZeneca AB, Director at Biolipox AB, Managing Director at Svecia Engineering AB, Director at Xintela AB, and Director at Mind The Byte SL.
He also served as an Independent Director at Xbrane Biopharma AB from 2015 to 2024.
Additionally, he has held positions as Principal at Astra AB and Pharmacia AB, Chief Scientific Officer at Biovitrum AB, Chief Scientific Officer & Head-R&D at Orexo AB from 2012 to 2015, and Chief Scientific Officer & Vice President at Swedish Orphan Biovitrum AB from 2010 to 2011.
He has also worked as a Professor at the University of Uppsala and as an Associate Professor at The Medical Products Agency.
Dr. Edman holds a doctorate degree from the University of Uppsala.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
XBRANE BIOPHARMA AB
0.01% | 31/12/2023 | 132 314 ( 0.01% ) | 3 748 $ | 31/05/2024 |
Posizioni attive di Kjell Rudolf Peter Edman
Società | Posizione | Inizio |
---|---|---|
Edman Life Science AB | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Kjell Rudolf Peter Edman
Società | Posizione | Fine |
---|---|---|
XBRANE BIOPHARMA AB | Direttore/Membro del Consiglio | 02/05/2024 |
OREXO AB | Direttore Tecnico/Scientifico/R&S | 01/06/2015 |
SWEDISH ORPHAN BIOVITRUM AB | Direttore Tecnico/Scientifico/R&S | 31/12/2011 |
XINTELA AB | Direttore/Membro del Consiglio | - |
Biolipox AB
![]() Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Direttore/Membro del Consiglio | - |
Formazione di Kjell Rudolf Peter Edman
University of Uppsala | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
OREXO AB | Health Technology |
XBRANE BIOPHARMA AB | Health Technology |
XINTELA AB | Health Technology |
Aziende private | 9 |
---|---|
Svecia Engineering AB
![]() Svecia Engineering AB Industrial MachineryProducer Manufacturing Svecia Engineering AB is a world-leading manufacturer of screen printing presses and ancillary equipment used extensively in the graphics, manufacturing and glass industries. Since its start-up in 1948, they have continuously introduced new ideas and products that have made screen printing a modern and reliable manufacturing technology. Today, more than 50 years later, their skills and dedication remain unchanged. Screen printing is still highly visual. Everyone can see how well you handle the mix of colors, materials and formats that characterizes the industry today. And everyone knows that the success of your business depends on the quality of your result. Committed to supplying innovative production solutions tailored to your total needs, their aim to increase your competitive edge and make you a first-choice supplier of screen printing services. | Producer Manufacturing |
Biovitrum AB
![]() Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
AstraZeneca AB
![]() AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Astra AB
![]() Astra AB Pharmaceuticals: MajorHealth Technology Astra AB used to manufacture and market cardiovascular preparations, local anesthetics, anti-infective agents and medical-care equipment. The firm's products were Pulmicort, Xylocaine, Marcaine, EMLA and Naropin. It had operations in Scandinavia, Europe, North & South America, Australia, New Zealand, Africa and Asia. The company was headquartered in Södertälje, Sweden. | Health Technology |
Pharmacia AB | Health Technology |
The Medical Products Agency
![]() The Medical Products Agency Pharmaceuticals: MajorHealth Technology The Medical Products Agency is a government agency based in Uppsala, Sweden. The agency is responsible for promoting public and animal health in Sweden with regards to pharmaceuticals, medical technology, and cosmetics. The agency is also known as the Swedish Medicines Agency and is tasked with ensuring the safety and efficacy of these products. | Health Technology |
Mind The Byte SL
![]() Mind The Byte SL Packaged SoftwareTechnology Services Mind The Byte SL develops software for drug discovery. | Technology Services |
Edman Life Science AB | |
Biolipox AB
![]() Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Health Technology |
- Borsa valori
- Insiders
- Kjell Rudolf Peter Edman